CELF1 and myotonic dystrophy type 1: With respect to RNA toxicity associated with DM1, previous studies have reported that PKCα/β signaling is activated in cells expressing expanded CUG repeat RNAs and that PKCα/β inhibition by Ro-31-8220 correlates with reduced PKCα/β activation and CELF1 levels [22].